All eyes on preliminary results from key remdesivir trial
Washington, April 27 (SocialNews.XYZ) After witnessing a controversial ‘inconclusive’ report last week, all eyes are now on preliminary results from a key global trial of US-based Gilead Sciences’ remdesivir, a potential antiviral drug to treat…